Skip to content
Ravi Tiku’s Perspective: Decoding Today’s Headlines

Ravi Tiku’s Perspective: Decoding Today’s Headlines

Always In Pursuit Of Excellence!

  • Home
  • Ravi Speaks
  • General
  • Entertainment
  • Finance News
  • Post and Opinion
  • Must See

Eli Lilly

Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

November 23, 2025
Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs Eli Lilly became the first U.S. health care company to reach a $1 trillion market value on November 21, 2025. …

Read more

Categories Finance News Tags Eli Lilly, Market cap, Mounjaro, TrumpRx, Zepbound

“Forget Mounjaro: Zepbound is Eli Lilly’s New Blockbuster Taking Over the Weight Loss Market”

August 20, 2024
"Forget Mounjaro: Zepbound is Eli Lilly's New Blockbuster Taking Over the Weight Loss Market"

Forget Mounjaro: Eli Lilly’s Next Big Blockbuster Has Arrived | The Motley Fool Eli Lilly has just introduced its next major blockbuster drug, Zepbound, and it’s making waves in the pharmaceutical industry. On Sunday, …

Read more

Categories Ravi Speaks Tags blockbuster drug, Eli Lilly, Obesity treatment, weight loss drug, Zepbound

“New Study Reveals Tirzepatide’s Impact on Blood Pressure: A Game-Changer for Obesity Management?”

February 7, 2024
"New Study Reveals Tirzepatide's Impact on Blood Pressure: A Game-Changer for Obesity Management?"

The Impact of Tirzepatide on Blood Pressure: A Breakthrough in Obesity and Diabetes Treatment The article discusses a recent study indicating significant reductions in blood pressure among overweight and obese patients taking the diabetes …

Read more

Categories Must See Tags Blood Pressure Reduction, Eli Lilly, Health research, Obesity management, Tirzepatide

“FDA Approves Eli Lilly’s Zepbound: A Game-Changer in Weight Management”

November 9, 2023
"FDA Approves Eli Lilly's Zepbound: A Game-Changer in Weight Management"

FDA approves Eli Lilly’s tirzepatide for weight loss | Fox Business The FDA has granted approval for Eli Lilly’s type 2 diabetes drug, tirzepatide, for use in chronic weight management. This approval formalizes the …

Read more

Categories Must See Tags Eli Lilly, FDA approval, healthcare advancements, weight management, Zepbound
Insightful Analysis Hub

 

🌟 Welcome to GOLDEN DEALS 🌟
Your new trusted destination for genuine Amazon deals, best offers, and value-for-money products 🛒
From today onward, this channel will share:
✅ Top Amazon deals & discounts
✅ Trending & useful products
✅ Honest recommendations
✅ Limited-time offers you shouldn’t miss
🔗 All links shared here are Amazon affiliate links
When you shop through them, you pay nothing extra, but it helps support this channel ❤️
📌 Amazon Affiliate Codes:
* amazon.com 👉rt0826-20
* amazon.in 👉ravitiku0c-21
Stay connected, stay smart, and grab the best Golden Deals before they’re gone! ✨
✨ Stay smart. Save more.
🛍️ Golden Deals = Smart Shopping
Happy Shopping! 🛍️




Just tap on the picture above


 

✔ VERIFIED EXPERT

Ravi Tiku

Professional Sales Expert
38+ Years | Ex-NSM (Multinational Pharma)

🏅 Gold Medalist 📘 Author 🏢 Pharma Leadership

Real-world sales and strategy insights shaped by four decades of leadership.

📩 Join my expert email list

Join Email List →
Those who aspire for sales-career.
5 Powerful Things to Know About Maha Shivaratri and Why It Still Matters Today5 Powerful Things to Know About Maha Shivaratri and Why It Still Matters TodayFebruary 15, 2026RAVI TIKU
Signs and Symptoms of Calcium Deficiency: Warning Signals Your Body Should Never IgnoreSigns and Symptoms of Calcium Deficiency: Warning Signals Your Body Should Never IgnoreFebruary 16, 2026RAVI TIKU
AI-Generated Movies Are Here: The Viral Deepfake Videos Shaking Hollywood and the Future of FilmAI-Generated Movies Are Here: The Viral Deepfake Videos Shaking Hollywood and the Future of FilmFebruary 14, 2026RAVI TIKU

  • facebook
  • x
  • instagram
  • linkedin
  • pinterest
  • Home
  • About us
  • CALCULATOR
  • Contact
  • Disclaimer
  • Web stories
  • Privacy Policy
  • All-purpose Calculator
  • Get Expert Insights
  • Subscribe
© 2026 Ravi Tiku’s Perspective: Decoding Today’s Headlines • Built with GeneratePress